Header Ads

Mylan Labs Gets Nod To Manufacture Remdesivir For COVID-19 Patients

July 03, 2020 ,
The Drug Controller General of India (DCGI) has granted permission to Mylan laboratories to manufacture and market the anti-viral drug remdesivir for ''restricted emergency use'' on hospitalised...

from NDTV News - India-news https://ift.tt/3gyo74L

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.